Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Global knowledge mapping and emerging research trends in the convergence of rheumatoid arthritis and exosomes: A CiteSpace-based visual analysis

Zhou Z., Hou M., Ling J., Liang R., Ou M., Yang M.

Laboratory Study on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Medicine (Baltimore) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Medicine (Baltimore) (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41088692
PMCID
PMC12517926
DOI
10.1097/md.0000000000044954

Abstract (original English)

Rheumatoid arthritis (RA) is an autoimmune disorder characterized by persistent synovial inflammation and progressive joint destruction, with a rising global prevalence. By 2050, the age-standardized incidence rate is projected to reach 16.78 per 1,00,000 women and 7.85 per 1,00,000 men. In recent years, exosomes (EXOs) - membrane-bound vesicles (30-150 nm in diameter) that mediate intercellular communication by shuttling proteins, nucleic acids, and lipids - have emerged as promising targets for unraveling RA pathogenesis and developing novel therapies. As key carriers of biological signals, EXOs regulate synovial microenvironment dynamics, including fibroblast-like synoviocyte activation, macrophage polarization, and inflammatory cytokine secretion, thereby playing dual roles in promoting or alleviating RA progression. However, research at this interdisciplinary nexus remains fragmented, lacking systematic synthesis. To address this gap, we employed CiteSpace software to generate a knowledge map from 244 Web of Science Core Collection documents (2000-2025), analyzing global research trends, thematic evolution, and collaborative networks. Key findings include: Growth in academic output: the number of publications continues to rise year by year, with the total number of citations exceeding 9723, significantly enhancing academic influence. Geographical distribution: China leads

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansArthritis, RheumatoidBiomedical ResearchExosomes

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research